Brawn Biotech Quarterly Results for Trading Insights
In Mar 2023, Brawn Biotech (BRAWN) reported revenue ₹0 Cr and net profit ₹0 Cr. Also explore BRAWN share price data to track price trends across different timeframes.
BRAWN Quarterly Results — Revenue, Profit & EPS Highlights
Brawn Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Brawn Biotech stock price NSE.
- Operating Margin of 25.0% in Mar 2023 (+58.0pp vs Jun 2023)
- Earnings Per Share of ₹0.47 in Mar 2023 (+687.5% vs Jun 2023)
Brawn Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS
BRAWN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2023 | Jun 2023 | Jun 2022 | QoQ | YoY |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 0 | 0 | - | - |
| Net Profit (₹ Cr) | 0 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 0 | 0 | 0 | - | - |
| EPS (₹) | 0.47 | -0.08 | 0.05 | - | - |
| Operating Margin (%) | 25.0% | -33.0% | 25.0% | - | - |
BRAWN Share Price Trend — 1-Year Movement Across Quarterly Results
Brawn Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with Brawn Biotech valuation methods to assess whether the stock is under or overvalued.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
BRAWN vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Brawn Biotech latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹450,643.09 Cr | 1882.3 | 14,875 | 3,125 | +10.8% | - | 21.0% | 144.8 |
|
Divis Laboratories
Sept 2025 |
₹179,470.03 Cr | 6912.0 | 2,860 | 689 | +7.1% | - | 24.1% | 266.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,702.77 Cr | 4460.1 | 3,219 | 591 | +11.3% | - | 18.4% | 254.3 |
|
Cipla
Mar 2026 |
₹115,205.68 Cr | 1409.8 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 205.2 |
|
Dr Reddys Laborator…
Mar 2026 |
₹111,107.68 Cr | 1335.2 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 503.8 |
All amounts in ₹ Crores